"10.1371_journal.ppat.1002061","plos pathogens","2011-06-02T00:00:00Z","Giovanni Sitia; Matteo Iannacone; Roberto Aiolfi; Masanori Isogawa; Nico van Rooijen; Cristina Scozzesi; Marco E Bianchi; Ulrich H von Andrian; Francis V Chisari; Luca G Guidotti","Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy; Immune Disease Institute and Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Immunology & Microbial Sciences, The Scripps Research Institute, La Jolla, California, United States of America; Department of Molecular Cell Biology, Free University Medical Center, Amsterdam, The Netherlands; DiaPro Diagnostic Bioprobes, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy; Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milan, Italy","Conceived and designed the experiments: G. Sitia, M. Iannacone, F. Chisari, L. Guidotti. Performed the experiments: G. Sitia, M. Iannacone, R. Aiolfi, M. Isogawa, L. Guidotti. Analyzed the data: G. Sitia, M. Iannacone, R. Aiolfi, M. Isogawa, U. von Andrian, F. Chisari, L. Guidotti. Contributed reagents/materials/analysis tools: N. van Rooijen, C. Scozzesi, M. Bianchi. Wrote the paper: G. Sitia, M. Iannacone, F. Chisari, L. Guidotti.","I have read the journals policy and have the following conflicts: MEB is founder and part owner of HMGBiotech, a company that provides goods and services related to HMGB proteins. CS works at DiaPro Diagnostic Bioprobes, a company that provides goods and services related to a variety of diagnostics. The authors have no additional financial interests.","2011","06","Giovanni Sitia","GS",10,TRUE,1,1,1,1,TRUE,TRUE,TRUE,7,"2;3;4;6;7;8;9",TRUE
